Trial · NCT05386459
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Comparative analysis between treatment groups on the WHO Clinical Improvement Scale | Day 14 | The assessment was carried out according to the WHO Clinical Improvement Scale from 0 points - not infected, no manifestations or virological signs of infection, up to 8 points - died, death |
| Secondary | Difference between laboratory LDH values | Day 14 | Difference between laboratory LDH values compared to baseline |
| Secondary | Difference between laboratory CRP values | Day 14 | Difference between laboratory CRP values compared to baseline |
| Secondary | Difference between laboratory ferritin values | Day 14 | Difference between laboratory ferritin values compared to baseline |
| Secondary | Changes in laboratory parameter D-dimer | Day 14 | Changes in laboratory parameter D-dimer compared with baseline |
| Secondary | Comparative analysis of survival between treatment groups | Day 14 | Comparative assessment of CFR mortality rates |
| Secondary | Comparative analysis of survival between treatment groups | Day 14 | Comparative assessment of IFR mortality rates |
| Secondary | Change from baseline patient ratings of subjective outcomes based on various measures | Day 14 | Change from Baseline Patients in Subjective Outcomes Based on: Pulse Oxygen Saturation |
| Secondary | Change from baseline patient ratings of subjective outcomes based on various measures | Day 14 | Change from baseline patient assessments of subjective outcomes based on the indicator: body temperature |
| Secondary | Change from baseline patient ratings of subjective outcomes based on various measures | Day 14 | Change from Baseline Patients in Subjective Outcomes Based on Indicator: Blood Pressure |
| Secondary | Comparative analysis between groups by indicators | Day 14 | Comparative analysis between groups by indicators: duration of fever |
| Secondary | Comparative analysis between groups by indicators | Day 14 | Comparative analysis between groups by indicators: duration of hospitalization |
| Secondary | Comparative analysis between groups on NEWS-2 indicators | Day 14 | Comparative assessment of the score according to the National Early Warning Rating 2 (NEWS-2), where the minimum score is 0, which corresponds to the general rules for managing a patient, from 7 points or more - emergency medical care is required in the ICU |
| Secondary | Comparative analysis of the incidence and severity of adverse events | Day 14 | Comparative analysis of the incidence and severity of adverse events according to CTCAE version 4.03 of 2010 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05386459/registered